301 related articles for article (PubMed ID: 19369350)
1. Development and characterization of a mouse model for Marburg hemorrhagic fever.
Warfield KL; Bradfute SB; Wells J; Lofts L; Cooper MT; Alves DA; Reed DK; VanTongeren SA; Mech CA; Bavari S
J Virol; 2009 Jul; 83(13):6404-15. PubMed ID: 19369350
[TBL] [Abstract][Full Text] [Related]
2. Development of a model for marburgvirus based on severe-combined immunodeficiency mice.
Warfield KL; Alves DA; Bradfute SB; Reed DK; VanTongeren S; Kalina WV; Olinger GG; Bavari S
Virol J; 2007 Oct; 4():108. PubMed ID: 17961252
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virus.
Qiu X; Wong G; Audet J; Cutts T; Niu Y; Booth S; Kobinger GP
J Virol; 2014 Nov; 88(21):12703-14. PubMed ID: 25142608
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model.
Cross RW; Fenton KA; Geisbert JB; Ebihara H; Mire CE; Geisbert TW
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S258-70. PubMed ID: 26092858
[TBL] [Abstract][Full Text] [Related]
5. Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.
Swenson DL; Warfield KL; Larsen T; Alves DA; Coberley SS; Bavari S
Expert Rev Vaccines; 2008 May; 7(4):417-29. PubMed ID: 18444889
[TBL] [Abstract][Full Text] [Related]
6. Key genomic changes necessary for an in vivo lethal mouse marburgvirus variant selection process.
Lofts LL; Wells JB; Bavari S; Warfield KL
J Virol; 2011 Apr; 85(8):3905-17. PubMed ID: 21289122
[TBL] [Abstract][Full Text] [Related]
7. A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever.
Marzi A; Banadyga L; Haddock E; Thomas T; Shen K; Horne EJ; Scott DP; Feldmann H; Ebihara H
Sci Rep; 2016 Dec; 6():39214. PubMed ID: 27976688
[TBL] [Abstract][Full Text] [Related]
8. Modelling Marburg Virus Disease in Syrian Golden Hamsters: Contrasted Virulence Between Angola and Ci67 Strains.
Cross RW; Fenton KA; Foster SL; Geisbert JB; Geisbert TW
J Infect Dis; 2023 Nov; 228(Suppl 7):S559-S570. PubMed ID: 37610176
[TBL] [Abstract][Full Text] [Related]
9. Amino Acid Residue at Position 79 of Marburg Virus VP40 Confers Interferon Antagonism in Mouse Cells.
Feagins AR; Basler CF
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S219-25. PubMed ID: 25926685
[TBL] [Abstract][Full Text] [Related]
10. A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model.
Keshwara R; Hagen KR; Abreu-Mota T; Papaneri AB; Liu D; Wirblich C; Johnson RF; Schnell MJ
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567978
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a guinea pig model for Marburg virus.
Wong G; Cao WG; He SH; Zhang ZR; Zhu WJ; Moffat E; Ebihara H; Embury-Hyatt C; Qiu XG
Zool Res; 2018 Jan; 39(1):32-41. PubMed ID: 29511143
[TBL] [Abstract][Full Text] [Related]
12. Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptor-deficient mice.
Lever MS; Piercy TJ; Steward JA; Eastaugh L; Smither SJ; Taylor C; Salguero FJ; Phillpotts RJ
J Med Microbiol; 2012 Jan; 61(Pt 1):8-15. PubMed ID: 21852521
[TBL] [Abstract][Full Text] [Related]
13. Immune Response to Marburg Virus Angola Infection in Nonhuman Primates.
Fernando L; Qiu X; Melito PL; Williams KJ; Feldmann F; Feldmann H; Jones SM; Alimonti JB
J Infect Dis; 2015 Oct; 212 Suppl 2():S234-41. PubMed ID: 25957966
[TBL] [Abstract][Full Text] [Related]
14. A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses.
Saito T; Maruyama J; Nagata N; Isono M; Okuya K; Takadate Y; Kida Y; Miyamoto H; Mori-Kajihara A; Hattori T; Furuyama W; Ogawa S; Iida S; Takada A
Viruses; 2020 Aug; 12(9):. PubMed ID: 32842671
[TBL] [Abstract][Full Text] [Related]
15. De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses.
Wang D; Schmaljohn AL; Raja NU; Trubey CM; Juompan LY; Luo M; Deitz SB; Yu H; Woraratanadharm J; Holman DH; Moore KM; Swain BM; Pratt WD; Dong JY
Vaccine; 2006 Apr; 24(15):2975-86. PubMed ID: 16530297
[TBL] [Abstract][Full Text] [Related]
16. A small nonhuman primate model for filovirus-induced disease.
Carrion R; Ro Y; Hoosien K; Ticer A; Brasky K; de la Garza M; Mansfield K; Patterson JL
Virology; 2011 Nov; 420(2):117-24. PubMed ID: 21959017
[TBL] [Abstract][Full Text] [Related]
17. A bioluminescent imaging mouse model for Marburg virus based on a pseudovirus system.
Zhang L; Li Q; Liu Q; Huang W; Nie J; Wang Y
Hum Vaccin Immunother; 2017 Aug; 13(8):1811-1817. PubMed ID: 28481728
[TBL] [Abstract][Full Text] [Related]
18. Deep-sequencing of Marburg virus genome during sequential mouse passaging and cell-culture adaptation reveals extensive changes over time.
Wei H; Audet J; Wong G; He S; Huang X; Cutts T; Theriault S; Xu B; Kobinger G; Qiu X
Sci Rep; 2017 Jun; 7(1):3390. PubMed ID: 28611428
[TBL] [Abstract][Full Text] [Related]
19. Protection against lethal Marburg virus infection mediated by lipid encapsulated small interfering RNA.
Ursic-Bedoya R; Mire CE; Robbins M; Geisbert JB; Judge A; MacLachlan I; Geisbert TW
J Infect Dis; 2014 Feb; 209(4):562-70. PubMed ID: 23990568
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated VP30 of Marburg Virus Is a Repressor of Transcription.
Tigabu B; Ramanathan P; Ivanov A; Lin X; Ilinykh PA; Parry CS; Freiberg AN; Nekhai S; Bukreyev A
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
